*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

Phesgo 600mg/600mg/10ml

Pertuzumab; Trastuzumab
600mg/10ml; 600mg/10ml
Injection

ROA

Subcutaneous

Applicant Name

Roche Products Limited

NRN

A6-100047

Status

Active


ATC Code

L01XY02  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 vial  

Product Description

Phesgo 600mg/600mg/10ml Pertuzumab and Trastuzumab Active Substances . Pertuzumab 600mg , trastuzumab 600mg Excipients Human hyaluronidase (rHuPH20) (produced by recombinant DNA technology using CHO [Chinese hamster ovary] cells) -, L-histidine hydrochloride monohydrate 36.1mg , L-histidine 4.40mg, a,a-trehalose dehydrate 397mg , sucrose 342mg , polysorbate 20* 4.00mg, L-methionine 14.9mg , water for injection QS to 10ml . A6-100047 Vaccines & Biologicals Biologics Imported Products 1 11/10/2021 Roche Products Limited, 8th Floor, Roche Office 21 Mobolaji Bank Anthony Way, Etiebet's Place, Ikeja. Lagos 8056292219 angela.essien@roche.com F.Hoffmann La Roche Limited, Wurmisweg 4303, Kaiseraugst, Switzerland, F.Hoffmann La Roche Limited, Wurmisweg 4303, Kaiseraugst, Switzerland, Switzerland

Manufacturer Name

F.Hoffmann La Roche Limited

Manufacturer Country

SWITZERLAND  

Approval Date

2022-11-02  

Expiry Date

2027-11-01